961.14(4)(tb)10.a.
a. 1-pentyl-N-(1-adamantyl)-1H-indazole-3-carboxamide, commonly known as AKB48;
961.14(4)(tb)10.b.
b. 1-(5-fluoropentyl)-N-(1-adamantyl)-1H-indazole-3-carboxamide, commonly known as 5F-AKB48.
961.14(4)(tb)11.
11. Any compound structurally derived from N-naphthyl-1H-indazole-3-carboxamide by substitution at either nitrogen atom of the indazole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indazole ring to any extent, whether or not substituted in the naphthyl ring to any extent.
961.14(4)(tb)12.
12. [1,1'-biphenyl]-3-yl-carbamic acid, cyclohexyl ester, commonly known as URB-602;
961.14(4)(tb)13.
13. [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate, commonly known as CP 50,556-1;
961.14(4)(tb)14.
14. (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol, commonly known as HU-210;
961.14(4)(tb)15.
15. (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol, commonly known as HU-211;
961.14(4)(tb)16.
16. 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione, commonly known as HU-331;
961.14(4)(tb)17.
17. ((6aR,10aR)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-9-yl)methanol, commonly known as JWH-051;
961.14(4)(tb)18.
18. (6aR,10aR)-3-(1,1-Dimethylbutyl)-6a,7,10,10a-tetrahydro -6,6,9-trimethyl-6H-dibenzo[b,d]pyran, commonly known as JWH-133;
961.14(4)(tb)19.
19. (6aR,10aR)-1-methoxy-6,6,9-trimethyl-3-[(2R)-1,1,2-trimethylbutyl]-6a,7,10,10a-tetrahydrobenzo[c]chromene, commonly known as JWH-359;
961.14(4)(tb)20.
20. Napthalen-1-yl-(4-pentyloxynapthalen-1-yl)methanone, commonly known as CB-13;
961.14(4)(tb)21.
21. N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-undecamide, commonly known as CB-25;
961.14(4)(tb)22.
22. N-cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-undecamide, commonly known as CB-52;
961.14(4)(tb)23.
23. N-(benzo[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-1,2-dihydroquinoline-3-carboxamide, commonly known as JTE-907;
961.14(4)(tb)24.
24. N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-ylidene]-2,2,3,3-tetramethylcyclopropane-1-carboxamide, commonly known as A-836,339;
961.14(4)(tb)25.
25. Anthracen-9-yl{2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methanone, commonly known as WIN 56,098;
961.14(4)(tb)26.
26. 6-methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazin-4-one, commonly known as URB-754;
961.14(4)(tb)27.
27. [3-(3-carbamoylphenyl)phenyl] N-cyclohexylcarbamate, commonly known as URB-597;
961.14(4)(tb)28.
28. (-)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluorobutyl-1-sulfonate, commonly known as BAY 38-7271.
961.14(4)(tb)29.
29. Any compound structurally derived from 1H-indole-3-carboxylic acid quinolinyl ester by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the quinoline ring to any extent. Substances specified under this subdivision include:
961.14(4)(tb)29.a.
a. 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester, commonly known as PB-22;
961.14(4)(tb)29.b.
b. 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester, commonly known as 5F-PB-22;
961.14(4)(tb)29.c.
c. 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester, commonly known as BB-22.
961.14(4)(tb)30.
30. Any compound structurally derived from N-naphthyl-1H-indole-3-carboxamide by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Substances specified under this subdivision include:
961.14(4)(tb)30.a.
a. 1-pentyl-N-(1-naphthyl)-1H-indole-3-carboxamide, commonly known as NNEI or MN-24;
961.14(4)(tb)30.b.
b. 1-(5-fluoropentyl)-N-(1-naphthyl)-1H-indole-3-carboxamide, commonly known as 5F-NNEI or 5F-MN-24.
961.14(4)(tb)31.
31. Any compound structurally derived from 3-(pyridinoyl)indole by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the pyridine ring to any extent. Substances specified under this subdivision include:
961.14(4)(tb)32.
32. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, commonly known as AB-FUBINACA.
961.14(4)(tb)33.
33. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, commonly known as ADB-PINACA.
961.14(4)(u)
(u) 1-[1-(2-thienyl)cyclohexyl]piperidine, which is the thiophene analog of phencyclidine;
961.14(4)(ud)
(ud) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, which is the thiophene pyrrolidine analog of phencyclidine;
961.14(4)(ug)
(ug) N-ethyl-1-phenylcyclohexylamine, which is the ethylamine analog of phencyclidine;
961.14(4)(ur)
(ur) 1-(1-phenylcyclohexyl)pyrrolidine, which is the pyrrolidine analog of phencyclidine;
961.14(4)(uv)
(uv) 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone, commonly known as methoxetamine.
961.14(4)(w)
(w) 4-bromo-2,5-dimethoxyamphetamine, commonly known as “DOB";
961.14(4)(wa)
(wa) 4-iodo-2,5-dimethoxyamphetamine, commonly known as DOI.
961.14(4)(wb)
(wb) 4-chloro-2,5-dimethoxyamphetamine, commonly known as DOC.
961.14(4)(wg)
(wg) 4-bromo-2,5-dimethoxy-beta-phenylethylamine, commonly known as “2C-B" or “Nexus";
961.14(4)(wgm)
(wgm) 4-iodo-2,5-dimethoxy-beta-phenylethylamine, commonly known as “2C-I".
961.14(4)(wh)
(wh) 2,5 dimethoxy-4-(n)-propylthiophenethylamine, commonly known as “2C-T-7";
961.14(4)(wi)
(wi) Alpha-methyltryptamine, commonly known as “AMT";
961.14(4)(wj)
(wj) 5-methoxy-N, N-diisopropyltryptamine, commonly known as “5-MeO-DIPT";
961.14(4)(wk)
(wk) 2,5-dimethoxy-4-ethylphenethylamine, commonly known as 2C-E.
961.14(4)(wL)
(wL) 2,5-dimethoxy-4-methylphenethylamine, commonly known as 2C-D.
961.14(4)(wm)
(wm) 2,5-dimethoxy-4-chlorophenethylamine, commonly known as 2C-C.
961.14(4)(wn)
(wn) 2,5-dimethoxy-4-ethylthiophenethylamine, commonly known as 2C-T-2.
961.14(4)(wo)
(wo) 2,5-dimethoxy-4-isopropylthiophenethylamine, commonly known as 2C-T-4.
961.14(4)(wp)
(wp) 2,5-dimethoxyphenethylamine, commonly known as 2C-H.
961.14(4)(wq)
(wq) 2,5-dimethoxy-4-nitrophenethylamine, commonly known as 2C-N.
961.14(4)(wr)
(wr) 2,5-dimethoxy-4-(n)-propylphenethylamine, commonly known as 2C-P.
961.14(4)(ws)
(ws) Any compound structurally derived from N-benzyl-2-(2,5-dimethoxyphenyl)ethanamine by substitution at the nitrogen atom, or on either ring, with alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, halide or nitro substituents, or by any combination of these modifications. Substances specified under this paragraph include:
961.14(4)(ws)1.
1. 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, commonly known as 25I-NBOMe.
961.14(4)(ws)2.
2. 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, commonly known as 25C-NBOMe.
961.14(4)(ws)3.
3. 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, commonly known as 25B-NBOMe.
961.14(4)(ws)4.
4. 2-(4-ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, commonly known as 25E-NBOMe.
961.14(4)(wv)
(wv) N,N-diallyl-5-methoxytryptamine, commonly known as 5-MeO-DALT.
961.14(4)(ww)
(ww) 5-(2-aminopropyl)benzofuran, commonly known as 5-APB.
961.14(4)(wx)
(wx) 6-(2-aminopropyl)benzofuran, commonly known as 6-APB.
961.14(4)(wy)
(wy) 5-(2-aminopropyl)-2,3-dihydrobenzofuran, commonly known as 5-APDB.
961.14(4)(wz)
(wz) 6-(2-aminopropyl)-2,3-dihydrobenzofuran, commonly known as 6-APDB.
961.14(4)(x)
(x) 4-methoxyamphetamine, commonly known as “PMA."
961.14(4)(xa)
(xa) 5-iodo-2-aminoindane, commonly known as 5-IAI.
961.14(4)(xb)
(xb) 4-methoxymethamphetamine, commonly known as PMMA.
961.14(5)
(5) Depressants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.14(5)(ag)
(ag) Gamma-hydroxybutyric acid (commonly known as gamma hydroxybutyrate or “GHB"), gamma-butyrolactone, and 1,4-butanediol.
961.14(6)
(6) Immediate precursors. Any material, compound, mixture or preparation which contains any quantity of any of the following substances or their salts:
961.14(7)
(7) Stimulants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.14(7)(L)
(L)
Substituted cathinones. Any compound, except bupropion or compounds scheduled elsewhere in this chapter, that is structurally derived from 2-amino-propan-1-one by substitution at the 1-position with either phenyl, napthyl, or thiophene ring systems, whether or not the compound is further modified in any of the following ways: by substitution in the ring system to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents; by substitution at the 3-position with an acyclic alkyl substituent; by substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups; by inclusion of the 2-amino nitrogen atom in a cyclic structure; or by any combination of these modifications. Substances specified under this subdivision include:
961.14(7)(L)3.
3. 4-methylmethcathinone, commonly known as mephedrone or 4-MMC.
961.14(7)(L)5.
5. 4-methoxy-alpha-pyrrolidinopropiophenone, commonly known as MOPPP.
961.14(7)(L)6.
6. 3,4-methylenedioxy-alpha-pyrrolidinopropiophenone, commonly known as MDPPP.
